森遠股份(300210.SZ):5名董監高擬合計減持不超19.9萬股
格隆匯10月16日丨森遠股份(300210.SZ)公佈,公司於近日接到公司董事、總經理孫斌武,董事於健、周偉,監事趙憶民、張秀傑關於減持公司股份計劃的告知函。上述人士擬自該公告之日起15個交易日後的6個月內(窗口期不減持)通過集中競價方式減持公司股份。
其中,孫斌武計劃減持公司股份4.4738萬股,佔公司總股本的0.0092%;於健計劃減持公司股份7.7566萬股,佔公司總股本的0.0160%;周偉計劃減持公司股份7.4431萬股,佔公司總股本的0.0154%;趙憶民計劃減持公司股份1410股,佔公司總股本的0.0003%;張秀傑計劃減持公司股份900股,佔公司總股本的0.0002%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.